MANY older adults with cancer are being prescribed preventive medications at the end of their lives that may harm their quality of life, as a result of failure to deprescribe, research reveals.
The study, published online in Cancer, found that deprescribing strategies need to be more widely adopted to help reduce the burden of drugs that have limited clinical benefit near the end of life.
The above article was sent to subscribers in Pharmacy Daily's issue from 29 May 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 May 19
